πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

57 results for β€œinactivated” Clear

  1. Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial
  2. Inactivated SARS-CoV-2 Vaccine (Vero cellοΌ‰

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial
  3. Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SARS-CoV-2 Infection

    approved mab active

    1 trial
  4. Quadrivalent Influenza Vaccine (Split Virion), inactivated

    Sinovac Research and Development Co.,

    Seasonal Influenza

    approved mab completed

    1 trial
  5. SARS-CoV-2 Inactivated Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    2 trials
  6. The live attenuated varicella vaccine and the inactivated hepatitis A vaccine

    Sinovac Research and Development Co.,

    Varicella

    approved mab completed

    1 trial
  7. Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial
  8. inactivated EV71 vaccine (KMB-17 cells)

    Chinese University of Hong Kong

    Hand, Foot and Mouth Disease (HFMD)

    approved mab completed

    1 trial
  9. Inactivated influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources